Cancer Research UK logo.
SearchDonate
  • Search

A study looking at how to diagnose mouth cancer (PANDORA)

Overview

Cancer types:

Head and neck cancers, Mouth and oropharyngeal cancer

Status:

Closed

Phase:

Other

Details

This study is looking at a new way to diagnose mouth cancer.

To diagnose mouth cancer doctors often cut a small piece of tissue from the affected area. This is called a scalpel biopsy. By looking at the tissue under the microscope, they can see if the cells are cancerous.

In this study the researchers are looking at a new way of collecting cells without taking a scalpel biopsy. They are also looking at a new way to test whether the cells are cancerous. They will use a small brush (like a toothbrush) to collect the cells. This is called a brush biopsy. They will then test the cells using a method called dielectrophoresis (dye-el-ek-tro-for-ee-sis).

Dielectrophoresis involves putting the cells into a device that contains an electric field and a small camera to watch their movements. As cancerous cells are different from normal cells, their movements within the electric field should be different. We know from that cancer cells and normal cells behave differently during dielectrophoresis.

The researchers will take brush biopsies from people who have mouth cancer and from people who don’t have mouth cancer. They will use dielectrophoresis on the cell samples and compare the results. The aims of this study are to find out

  • How well dielectrophoresis works in identifying cancer cells

  • If brush biopsies can collect enough cells to use for dielectrophoresis

Please note – you will not benefit directly from taking part in this study and it will not affect any treatment you may have. It is possible that the results of this study may help to improve how mouth cancer is diagnosed in the future.

Recruitment start: 1 August 2013

Recruitment end: 31 March 2015

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Stefano Fedele

Supported by

NIHR Clinical Research Network: Cancer

NIHR Invention for Innovation (i4i) Programme

University College London (UCL)

Last reviewed: 30 Mar 2015

CRUK internal database number: 10452

Help and support